RN7SL43P

Across TCGA pan-cancer cohorts, RN7SL43P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RN7SL43P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RN7SL43P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL43P expression acts as an unfavorable survival marker, although some lineages such as GBM and ESCA show a favorable association.

ACC, KICH, and KIRC are the cancer types where RN7SL43P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.169	0.679	.003	45	view →
KICH	DFS	Tertile	III,IV	0.025	0.773	<.001	39	view →
KIRC	DFS	Tertile	IV	0.226	0.537	<.001	36	view →
UVM	DFS	Tertile	All	0.244	0.760	.035	18	view →
THYM	OS	Tertile	III,IV	0.212	1.000	.014	18	view →
LGG	DFS	Tertile	All	0.692	0.844	.008	18	view →
STAD	DFS	Median	II,III,IV	0.559	0.791	.004	16	view →
PCPG	DFS	Tertile	All	0.533	0.855	.040	9	view →
GBM	OS	Median	All	0.341	0.213	.010	6	view →
THCA	DFS	Tertile	II,III,IV	0.738	0.879	.039	6	view →
ESCA	OS	Quartile	III,IV	0.614	0.281	.030	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RN7SL43P–ACC (DFS)

Open the ACC breakdown →